publication date: Apr. 12, 2019


story about robotic mastectomy that appeared in the April 5 issue of The Cancer Letter reported incorrectly that surgeon Stephen A. Chagares had performed robotic mastectomies at Monmouth Medical Center without a surgical trial protocol.

This error occurred because incorrect information was provided to The Cancer Letter by sources that would ordinarily be deemed to be knowledgeable. Repeated efforts had been made to obtain the answers from named sources on record, but were unsuccessful. We rely on unnamed sources on occasion, always checking whether they would be privy to information they provide.

We have since learned that there was a protocol, that patients were informed about the research risk and that they had signed informed consent forms. This detail doesn’t alter the main thesis and conclusions of the story, which focuses on studies of robotic mastectomy.

After learning that incorrect information had been given to us, The Cancer Letter submitted 32 questions to Monmouth, but received a response that we do not regard as informative:

“Of paramount concern to Monmouth Medical Center (MMC) is patient safety. After an evaluation of the robotic mastectomy procedure, MMC promptly suspended the procedure, pending additional investigation of its risks and benefits.”

Attorneys for Chagares also responded to The Cancer Letter, stating that the surgeon is precluded by the institutional review board rules from responding to questions from The Cancer Letter:

“Maggs & McDermott, LLC represents Stephen Chagares, M.D., with respect to the article regarding robotic mastectomy published by The Cancer Letter. Dr. Chagares received an email from Paul Goldberg setting forth a series of questions that The Cancer Letter believes are relevant with respect to the article. As you know, the surgical procedure discussed … Continue reading Corrections

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.